Clinical Trials

DermatologicGenitourinary

174 enrolled

Carcinoma, Transitional Cell, Melanoma

NCT07472322 2026-04-14

ASTX727 & Retifanlimab-dlwr for Advanced Merkel Cell After Progression on Anti-PD-(L)1

Phase 1/2 Not yet recruiting

31 enrolled

Carcinoma, Merkel Cell

NCT07527325 2026-04-14

Fianlimab&Cemiplimab as TotalNeoadj The (TNT) ForMelanoma

35 enrolled

Melanoma

NCT07529080 2026-04-14

Personalized Cancer Support (Thrive Track) to Manage the Emotional Needs of Young Adults With Thyroid, Melanoma and Testicular Cancer, PerCS-YA Trial

DermatologicEndocrineGenitourinaryHead & Neck

142 enrolled

Thyroid Cancer, Papillary, Melanoma, Testicular Neoplasms, Adenocarcinoma, Follicular

NCT07524062 2026-04-13

THERMS

120 enrolled

Postoperative Complications, Skin Neoplasms, Surgical Wound Infection

NCT07519655 2026-04-09

Phase 1 Study of PF-08046033 in Advanced Solid Tumors

DermatologicGastrointestinalThoracic

250 enrolled

Esophageal Neoplasms, Lung Neoplasms, Melanoma

NCT07517653 2026-04-08

Neoadjuvant SHR-1701 Plus Famitinib With Response-guided Adjuvant Therapy in Resectable Mucosal Melanoma

70 enrolled

Melanoma

NCT07513454 2026-04-07

A Phase 2 Study of HW211026 in Participants With Actinic Keratosis

80 enrolled

Keratosis, Actinic

NCT07511036 2026-04-06

PROSECCO: A Phase 2, Single Arm, Neoadjuvant Study Evaluating Combination Cemiplimab, Fianlimab, And Ipilimumab In Patients With Surgically Resectable Melanoma

20 enrolled

Melanoma

NCT07476326 2026-04-03

Pharmacokinetics, Safety, and Immunogenicity Comparison of Bmab1700 and Opdivo® as Adjuvant Monotherapy in Participants With Melanoma

120 enrolled

Phase EARLY_PHASE1 Not yet recruiting

Diabetes Mellitus, Insulin-Dependent, 12, Melanoma, Neoplasms

NCT07286318 2026-04-02

A Randomized Controlled Trial of Topical 5% Niacinamide for Skin Cancer Prevention in Transplant Recipients

20 enrolled

Phase 4 Not yet recruiting

Carcinoma, Basal Cell, Skin Neoplasms, Keratosis, Actinic

NCT07504796 2026-04-01

ctDNA-guided Addition of Ipilimumab to Patients Receiving Nivolumab and Relatlimab

90 enrolled

Melanoma

NCT07501104 2026-03-30

TRIUMPH-AM

30 enrolled

Melanoma

NCT07501117 2026-03-30

Neoadjuvant Immunotherapy for Patients With High-risk Eye Melanoma

15 enrolled

Uveal Melanoma

NCT07501780 2026-03-30

RELI

297 enrolled

Carcinoma, Carcinoma, Basal Cell, Neoplasms, Neoplasms, Basal Cell

NCT07492121 2026-03-25

GAPIMET

180 enrolled

DermatologicThoracic

Lung Neoplasms, Melanoma

NCT07492680 2026-03-25

A Study of BMS-986504 Monotherapy and in Combination With Other Agents in Participants With Advanced and/or Metastatic Solid Tumors With Homozygous MTAP Deletion (MountainTAP-5)

CNSDermatologicGastrointestinal

260 enrolled

Brain Neoplasms, Melanoma, Pancreatic Neoplasms

NCT06708455 2026-03-19

Phase 2b of RAPA-201 Cell Therapy in Post-PD-(L)-1 Melanoma

65 enrolled

Melanoma

NCT07482956 2026-03-19

BCC-One-Stop-Study

290 enrolled

Carcinoma, Basal Cell, Skin Neoplasms

NCT07241585 2026-03-17

Vitamin D Effects on Immune Microenvironment of Nonmelanoma Skin Cancer After Photodynamic Therapy (PDT)

54 enrolled

Carcinoma, Basal Cell, Carcinoma, Squamous Cell

NCT07475572 2026-03-16

A Randomized, Double-Blind, Pharmacokinetic Similarity Study to Compare AVT32-DRL_PB With Keytruda® in Participants With Fully Resected Melanoma

120 enrolled

Melanoma

NCT07237594 2026-03-11

REPLAY

4 enrolled

Melanoma

NCT07227350 2026-03-10

L19IL2 or L19TNF or L19IL2/TNF in Patients With Basal Cell Carcinoma (BCC)

180 enrolled

Carcinoma, Basal Cell

NCT07227870 2026-03-09

L19IL2/TNF in Patients With Basal Cell Carcinoma

92 enrolled

Phase 4 Not yet recruiting

Carcinoma, Basal Cell

NCT07459543 2026-03-09

A Study To Assess the Safety, and Tolerability of Nivolumab + Relatlimab Fixed-Dose Combination (FDC) In Untreated, Unresectable or Metastatic Melanoma Participants In India

30 enrolled

Melanoma, Skin Neoplasms

NCT07455331 2026-03-06

LANCE

60 enrolled

Carcinoma, Basal Cell, Skin Neoplasms

NCT07442292 2026-03-05

PD-L1 Targeting Peptide Probe for PET Imaging of Solid Tumor

40 enrolled

DermatologicThoracic

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Melanoma

NCT07280715 2026-03-03

IRIS

40 enrolled

Melanoma, Neoplasms

NCT07444606 2026-03-03

Dose Ranging, Toxicity Seeking, Phase 1 Trial of Oncolytic Adenoviral Therapy for Melanoma Intracranial and Extracranial Metastases

50 enrolled

Melanoma

NCT07437300 2026-02-27

FIBIOME

60 enrolled

Melanoma

NCT07406087 2026-02-25

Navigation Intervention for Adolescent and Young Adult Cancer Survivors

BreastDermatologicGastrointestinalGenitourinaryGynecologicHead & NeckSarcoma

25 enrolled

Breast Neoplasms, Uterine Cervical Neoplasms, Colonic Neoplasms, Melanoma, Ovarian Neoplasms, Sarcoma, Testicular Neoplasms, Thyroid Neoplasms, Endometrial Neoplasms

NCT07426484 2026-02-23

Cosibelimab for CSCC in Patients With Kidney Transplant or Hematologic Malignancy

Phase 4 Not yet recruiting

80 enrolled

DermatologicLymphoidOther hematologic neoplasmPlasma cell

Lymphoma, Waldenstrom Macroglobulinemia, Skin Neoplasms, Leukemia, Lymphocytic, Chronic, B-Cell, Neoplasms, Plasma Cell

NCT07405086 2026-02-12

Morning Versus Afternoon Administration of Immunotherapy for the Treatment of Advanced or Metastatic Solid Tumors, The Knight SHIFT Study

DermatologicGastrointestinalGenitourinaryHead & NeckThoracic

160 enrolled

Squamous Cell Carcinoma of Head and Neck, Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Carcinoma, Hepatocellular, Lung Neoplasms, Melanoma, Neoplasm Metastasis

NCT07406022 2026-02-12

OpticSkin

140 enrolled

Disease, Skin Neoplasms

NCT07406724 2026-02-12

HS-IT101 Injection Versus Chemotherapy in the Treatment of Advanced Melanoma

90 enrolled

Melanoma

NCT07401277 2026-02-10

Actinic Keratoses Treated With 5-fluorouracil Plus Aluminum

32 enrolled

Phase EARLY_PHASE1 Not yet recruiting

Keratosis, Actinic

NCT07389525 2026-02-05

Immune Checkpoint Inhibitor (ICI)-Drug-Drug Interaction (DDI) Study

80 enrolled

DermatologicGastrointestinalSarcoma

Gastrointestinal Neoplasms, Melanoma, Sarcoma, Urogenital Neoplasms

NCT07387198 2026-02-04

NeoMatryx

135 enrolled

Skin Neoplasms, Carcinoma, Merkel Cell

NCT07384078 2026-02-03

HIFUvsCRYO

294 enrolled

Bowen's Disease, Carcinoma, Basal Cell

NCT07376512 2026-01-29

EVpredict

378 enrolled

DermatologicThoracic

Carcinoma, Non-Small-Cell Lung, Melanoma

NCT07247123 2026-01-27

Developing and Testing the Effectiveness of a Skin Cancer Self-Detection Educational Program

280 enrolled

Skin Neoplasms

NCT07361666 2026-01-23

HFUS-CLEAR

400 enrolled

Phase 3 Not yet recruiting

Margins of Excision, Carcinoma, Basal Cell, Carcinoma, Squamous Cell, Recurrence, Skin Neoplasms

NCT05212246 2026-01-22

B3C

1,630 enrolled

Carcinoma, Basal Cell, Carcinoma, Squamous Cell, Patient Compliance, Keratosis, Actinic

NCT07358637 2026-01-22

Artificial Intelligence Enhanced Optical Coherence Tomography (AI-OCT) Imaging for Pre-surgical Margin Detection of Basal Cell Carcinoma

30 enrolled

Carcinoma, Basal Cell

NCT07354152 2026-01-21

COPERGRAM1

40 enrolled

Phase 1/2 Not yet recruiting

Melanoma

NCT07341737 2026-01-15

SL-28 for Advanced Solid Tumours

60 enrolled

BreastDermatologicGastrointestinalGenitourinaryGynecologicHead & NeckThoracic

Adenocarcinoma of Lung, Urinary Bladder Neoplasms, Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Esophageal Neoplasms, Head and Neck Neoplasms, Intestinal Neoplasms, Kidney Neoplasms, Liver Neoplasms, Lung Neoplasms, Melanoma, Neoplasm Metastasis, Ovarian Neoplasms, Pancreatic Neoplasms, Prostatic Neoplasms, Stomach Neoplasms, Colorectal Neoplasms, Endometrial Neoplasms

NCT07338968 2026-01-14

CoMpass

100 enrolled

Phase 1/2 Not yet recruiting

Uveal Melanoma

NCT07339176 2026-01-14

OP-NEU-101

275 enrolled

BreastDermatologicHead & NeckThoracic

Squamous Cell Carcinoma of Head and Neck, Carcinoma, Non-Small-Cell Lung, Carcinoma, Squamous Cell, Head and Neck Neoplasms, Melanoma, Neoplasm Metastasis, Neoplasms, Triple Negative Breast Neoplasms

NCT07340619 2026-01-14

EPIBREAST

51 enrolled